<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-NKC-2330</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2330</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Естественные киллеры: происхождение, фенотип, функции.</article-title><trans-title-group xml:lang="en"><trans-title>Natural killer cells: origin, phenotype, function</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тыщук</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyshchuk</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тыщук Елизавета Владимировна – лаборант-исследователь лаборатории межклеточных взаимодействий, отдел иммунологии и межклеточных взаимодействий.</p><p>199034, Санкт-Петербург, Менделеевская линия, 3. Тел.: 8 (931) 963-85-78</p></bio><bio xml:lang="en"><p>Tyshchuk Elizaveta V. - Research Assistant, Laboratory of Intercellular Interactions, Department of Immunology and Intercellular Interactions, D. Ott RIOGR.</p><p>199034, St. Petersburg, Mendeleevskaya line, 3. Phone: 7 (931) 963-85-78.</p></bio><email xlink:type="simple">tyshhuk.elizaveta@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhailova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат биологических наук, старший научный сотрудник лаборатории межклеточных взаимодействий, отдел иммунологии и межклеточных взаимодействий НИИАГР имени Д.О. Отта; кафедра иммунологии Первый С-ПбГМУ имени академика И.П. Павлова.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD (Biology), Senior Research Associate, Laboratory of Intercellular Interactions, Department of Immunology and Intercellular Interactions, D. Ott RIOGR; Department of Immunology, First St. Petersburg State I. Pavlov MU.</p><p>St. Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сельков</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Selkov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, заслуженный деятель науки РФ, заведующий отделом иммунологии и межклеточных взаимодействий НИИАГР имени Д.О. Отта; профессор кафедры иммунологии Первый С-ПбГМУ имени академика И.П. Павлова.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Honored Science Worker, Head, Department of Immunology and Intercellular Interactions, D. Ott RIOGR; Professor, Department of Immunology, First St. Petersburg State I. Pavlov MU.</p><p>St. Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соколов</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokolov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор биологических наук, заведующий лабораторией межклеточных взаимодействий, отдел иммунологии и межклеточных взаимодействий НИИАГР имени Д.О. Отта; кафедра иммунологии Первый С-ПбГМУ имени академика И.П. Павлова.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>PhD, MD (Biology), Head, Laboratory of Intercellular Interactions, Department of Immunology and Intercellular Interactions, D. Ott Research Institute of Obstetrics, Gynecology and Reproductology; Department of Immunology, First St. Petersburg State I. Pavlov MU.</p><p>St. Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта</institution><country>Россия</country></aff><aff xml:lang="en"><institution>D. Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта; ФГБОУ ВО Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>D. Ott Research Institute of Obstetrics, Gynecology and Reproductology, St. Petersburg, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2021</year></pub-date><volume>23</volume><issue>6</issue><fpage>1207</fpage><lpage>1228</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тыщук Е.В., Михайлова В.А., Сельков С.А., Соколов Д.И., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Тыщук Е.В., Михайлова В.А., Сельков С.А., Соколов Д.И.</copyright-holder><copyright-holder xml:lang="en">Tyshchuk E.V., Mikhailova V.A., Selkov S.A., Sokolov D.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2330">https://www.mimmun.ru/mimmun/article/view/2330</self-uri><abstract><p>NK-клетки (от Natural killer), или естественные киллеры, представляют собой группу лимфоцитов врожденного иммунитета, образующихся в костном мозге. Выделение NK-клеток в отдельную популяцию лимфоцитов связано с открытием их способности индуцировать гибель опухолевых клеток без предварительной сенсибилизации. В настоящем обзоре предпринята попытка систематизации представленных в литературе многочисленных данных о биологии NK-клеток. Авторами рассмотрены этапы дифференцировки NK-клеток из общего лимфоидного предшественника (CLP) в костном мозге, описаны две функционально различные популяции зрелых NK-клеток – CD56brightCDl6- и CD56dimCD16+. Кроме того, обсуждается роль цитокинов и хемокинов в развитии NK-клеток. В обзоре собраны данные о спектре экспрессируемых NK-клетками адгезионных молекул (LFA-1, LFA-2, LFA-3; αMβ2, αXβ2, L-selectin, VLA-4, VLA-5; PECAM-1; CEACAM-1), цитокиновых рецепторов (IL-1R, IL-2ra, IL-2Rb/IL-2Rc, IL-6Rα, IL-7Ra, IL-8R, IL-10R, IL-12Rβ1, IL-15ra, IL-18R, IL-21ra, IFNGR2, TGFBR, c-Kit, CXCR1, CXCR3, CXCR4, CCR4, CCR5, CCR6, CCR7, IChemR23, CX3CR1), а также рецепторов, регулирующих активность NK-клеток (LILRB1, LILRB2, LILRB4; KIR2DL1-5; KIR2DS1-5; KIR3DL1-3; KIR3DS1; NKG2A, NKG2C, NKG2D; Siglec7, Siglec9; CD16; NKRP-1; TIGIT; TACTILE; NKp30, NKp44, NKp46, NKp80; LAIR-1; PD-1; TIM-3; 2B4; TLR1-9). Авторами также рассмотрены механизмы реализации NK-клетками цитотоксической активности, в том числе за счет экспрессии MHC-I-специфических рецепторов, Fc-рецепторов CD16, взаимодействия рецепторов и лигандов апоптоза (Fas-FasL и TRAIL-TRAILR), а также других рецепторов. В обзоре подробно описано строение иммунологического синапса между NK-клеткой и клеткой-мишенью, рецепторные взаимодействия и роль цитоскелета при его формировании. Помимо активирующего иммунологического синапса, в обзоре описывается ингибирующий вариант, а также приведен пример регуляции активности NK-клеток посредством ингибирующего синапса. Авторами суммированы данные о способах экзоцитоза литических гранул NK-клетками, включающих полное или частичное слияние везикул с плазматической мембраной, экзоцитоз везикул, содержащих перфорин и FasL, и образование микровезикул, содержащих гранзим B. В обзоре описаны данные о способности NK-клеток сохранять активированное состояние в течение продолжительного времени, а также поддерживать контакт одновременно с несколькими мишенями. Помимо функций, свойственных естественным киллерам как клеткам врожденного иммунитета, авторы указывают на их способность проявлять черты клеток адаптивного иммунитета. В целом, разнообразие механизмов, регулирующих активность NK-клеток, дополняет специфические функции лимфоцитов, что делает работу иммунной системы более эффективной.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>Natural killer cells (NK) are innate immune lymphocytes produced in the bone marrow. Isolation of NK cells as a separate population of lymphocytes is related to discovery of their ability to induce the death of tumor cells without prior sensitization. In this review, an attempt was made to systematize the numerous data on the biology of NK cells presented in the literature. The authors consider the stages of NK cells` differentiation from a common lymphoid progenitor (CLP) in the bone marrow, describe two functionally different populations of mature NK cells – CD56brightCDl6- and CD56dimCD16+. In addition, the role of cytokines and chemokines in the development of NK cells is discussed. The review includes data on the spectrum of molecules expressed by NK cells: adhesion molecules (LFA-1, LFA-2, LFA-3; αMβ2, αXβ2, L-selectin, VLA-4, VLA-5; PECAM-1; CEACAM-1), cytokine receptors (IL-1R, IL-2ra, IL-2Rb/IL-2Rc, IL-6Rα, IL-7Ra, IL-8R, IL-10R, IL-12Rβ1, IL-15ra, IL-18R, IL-21ra, IFNGR2, TGFBR, c-Kit, CXCR1, CXCR3, CXCR4, CCR4, CCR5, CCR6, CCR7, IChemR23, CX3CR1), as well as receptors that regulate the activity of NK cells (LILRB1, LILRB2, LILRB4; KIR2DL1-5; KIR2DS1-5; KIR3DL1-3; KIR3DS1; NKG2A, NKG2C, NKG2D; Siglec7, Siglec9; CD16; NKRP-1; TIGIT; TACTILE; NKp30, NKp44, NKp46, NKp80; LAIR-1; PD-1; TIM-3; 2B4; TLR1-9). The authors also examine the mechanisms of implementing cytotoxic activity by NK cells, including cytotoxicity, via expression of MHC-I-specific receptors, CD16 Fc receptors, receptors and ligands of apoptosis (Fas-FasL and TRAIL-TRAILR) as well as other receptors. The review describes in detail the structure of immunological synapse between the NK cell and target cell, receptor interactions, and the role of the cytoskeleton in its formation. The data are summarized on the variants of exocytosis of lytic granules by NK cells, including complete or partial fusion of vesicles with the plasma membrane, exocytosis of vesicles containing perforin and FasL, and the formation of microvesicles containing granzyme B. The review also describes data on ability of NK cells to maintain activated state for a long time, as well as to maintain contact with several targets at the same time. In addition to the functions inherent in natural killers as cells of innate immunity, the authors point out their ability to exhibit the features of cells of adaptive immunity. In general, a variety of mechanisms that regulate the activity of NK cells may complement the specific functions of lymphocytes, thus making the immune system more efficient.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>NK-клетки</kwd><kwd>дифференцировка</kwd><kwd>рецепторы</kwd><kwd>цитотоксичность</kwd><kwd>иммунологический синапс</kwd><kwd>цитокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>NK-клетки</kwd><kwd>дифференцировка</kwd><kwd>рецепторы</kwd><kwd>цитотоксичность</kwd><kwd>иммунологический синапс</kwd><kwd>цитокины</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа поддержана грантом РНФ № 21-15-00021</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Коваленко Е.И., Стрельцова М.А. Адаптивные свойства натуральных киллеров – лимфоцитов врожденного иммунитета // Биоорганическая химия, 2016. Т. 42, № 6. С. 649-667.</mixed-citation><mixed-citation xml:lang="en">Kovalenko E.I., Streltsova M.A. Adaptive features of natural killer cells, lymphocytes of innate immunity. Bioorganicheskaya khimiya = Russian Journal of Bioorganic Chemistry, 2016, Vol. 42, no. 6, pp. 649-667. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлова В.А. Лимфоциты врожденного иммунитета эндометрия и децидуальной оболочки человека // Иммунология, 2019. Т. 40, № 3. С. 83-92.</mixed-citation><mixed-citation xml:lang="en">Mikhailova V.A. Innate lymphoid cells of human endometrium and decidua. Immunologiya= Immunologiya, 2019, Vol. 40, no. 3, pp. 83-92. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлова В.А., Онохина Я.С., Сельков С.А., Соколов Д.И. Экспрессия адгезионных молекул и хемокиновых рецепторов NK-клетками периферической крови при беременности // Иммунология, 2011. Т. 32, № 2. С. 78-81.</mixed-citation><mixed-citation xml:lang="en">Mikhailova V.A., Onokhina Ya.S., Selkov S.A., Sokolov D.I. Expression of adhesion molecules and chemokine receptors by peripheral blood NK-cells in pregnancy. Immunologiya = Immunologiya, 2011, Vol. 32, no. 2, pp. 78-81. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Михайлова В.А., Сельков С.А., Соколов Д.И. Фенотипические и функциональные характеристики NK–клеток при беременности // Акушерство и гинекология, 2011. № 5. С. 4-9.</mixed-citation><mixed-citation xml:lang="en">Mikhailova V.A., Selkov S.A., Sokolov D.I. Phenotypic and functional characteristics of NK cells in pregnancy. Akusherstvo i ginekologiya = Obstetrics and Gynecology, 2011, no. 5, pp. 4-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ярилин А.А. Иммунология. М.: ГЭОТАР-Медиа, 2011. 752 с.</mixed-citation><mixed-citation xml:lang="en">Yarilin A.A. Immunology]. Moscow: GEOTAR-Media, 2011. 752 p</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Abel A.M., Yang C., Thakar M.S., Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front. Immunol., 2018, Vol. 9, 1869. doi: 10.3389/fimmu.2018.01869.</mixed-citation><mixed-citation xml:lang="en">Abel A.M., Yang C., Thakar M.S., Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front. Immunol., 2018, Vol. 9, 1869. doi: 10.3389/fimmu.2018.01869.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Abrahams V.M., Straszewski-Chavez S.L., Guller S., Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod., 2004, Vol. 10, no. 1, pp. 55-63.</mixed-citation><mixed-citation xml:lang="en">Abrahams V.M., Straszewski-Chavez S.L., Guller S., Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod., 2004, Vol. 10, no. 1, pp. 55-63.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Adib-Conquy M., Scott-Algara D., Cavaillon J.M., Souza-Fonseca-Guimaraes F. TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals. Immunol. Cell Biol., 2014, Vol. 92, no. 3, pp. 256-262.</mixed-citation><mixed-citation xml:lang="en">Adib-Conquy M., Scott-Algara D., Cavaillon J.M., Souza-Fonseca-Guimaraes F. TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals. Immunol. Cell Biol., 2014, Vol. 92, no. 3, pp. 256-262.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Allan D.S., Rybalov B., Awong G., Zuniga-Pflucker J.C., Kopcow H.D., Carlyle J.R., Strominger J.L. TGFbeta affects development and differentiation of human natural killer cell subsets. Eur. J. Immunol., 2010, Vol. 40, no. 8, pp. 2289-2295.</mixed-citation><mixed-citation xml:lang="en">Allan D.S., Rybalov B., Awong G., Zuniga-Pflucker J.C., Kopcow H.D., Carlyle J.R., Strominger J.L. TGFbeta affects development and differentiation of human natural killer cell subsets. Eur. J. Immunol., 2010, Vol. 40, no. 8, pp. 2289-2295.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ander S.E., Diamond M.S., Coyne C.B. Immune responses at the maternal-fetal interface. Sci. Immunol., 2019, Vol. 4, no. 31, eaat6114. doi: 10.1126/sciimmunol.aat6114.</mixed-citation><mixed-citation xml:lang="en">Ander S.E., Diamond M.S., Coyne C.B. Immune responses at the maternal-fetal interface. Sci. Immunol., 2019, Vol. 4, no. 31, eaat6114. doi: 10.1126/sciimmunol.aat6114.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J. Exp. Med., 2002, Vol. 196, no. 4, pp. 493-503.</mixed-citation><mixed-citation xml:lang="en">Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J. Exp. Med., 2002, Vol. 196, no. 4, pp. 493-503.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Banerjee P.P., Pandey R., Zheng R., Suhoski M.M., Monaco-Shawver L., Orange J.S. Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse. J. Exp. Med., 2007, Vol. 204, no. 10, pp. 2305-2320.</mixed-citation><mixed-citation xml:lang="en">Banerjee P.P., Pandey R., Zheng R., Suhoski M.M., Monaco-Shawver L., Orange J.S. Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse. J. Exp. Med., 2007, Vol. 204, no. 10, pp. 2305-2320.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Barber D.F., Faure M., Long E.O. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol., 2004, Vol. 173, no. 6, pp. 3653-3659.</mixed-citation><mixed-citation xml:lang="en">Barber D.F., Faure M., Long E.O. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol., 2004, Vol. 173, no. 6, pp. 3653-3659.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bender A.T., Tzvetkov E., Pereira A., Wu Y., Kasar S., Przetak M.M., Vlach J., Niewold T.B., Jensen M.A., Okitsu S.L. TLR7 and TLR8 differentially activate the IRF and NF-kappaB pathways in specific cell types to promote inflammation. Immunohorizons, 2020, Vol. 4, no. 2, pp. 93-107.</mixed-citation><mixed-citation xml:lang="en">Bender A.T., Tzvetkov E., Pereira A., Wu Y., Kasar S., Przetak M.M., Vlach J., Niewold T.B., Jensen M.A., Okitsu S.L. TLR7 and TLR8 differentially activate the IRF and NF-kappaB pathways in specific cell types to promote inflammation. Immunohorizons, 2020, Vol. 4, no. 2, pp. 93-107.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Berahovich R.D., Lai N.L., Wei Z., Lanier L.L., Schall T.J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol., 2006, Vol. 177, no. 11, pp. 7833-7840.</mixed-citation><mixed-citation xml:lang="en">Berahovich R.D., Lai N.L., Wei Z., Lanier L.L., Schall T.J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol., 2006, Vol. 177, no. 11, pp. 7833-7840.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bernardini G., Gismondi A., Santoni A. Chemokines and NK cells: regulators of development, trafficking and functions. Immunol. Lett., 2012, Vol. 145, no. 1-2, pp. 39-46.</mixed-citation><mixed-citation xml:lang="en">Bernardini G., Gismondi A., Santoni A. Chemokines and NK cells: regulators of development, trafficking and functions. Immunol. Lett., 2012, Vol. 145, no. 1-2, pp. 39-46.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstone L., van Wilgenburg B., James W. Several commercially available anti-CCR5 monoclonal antibodies lack specificity and should be used with caution. Hybridoma (Larchmt), 2012, Vol. 31, no. 1, pp. 7-19.</mixed-citation><mixed-citation xml:lang="en">Bernstone L., van Wilgenburg B., James W. Several commercially available anti-CCR5 monoclonal antibodies lack specificity and should be used with caution. Hybridoma (Larchmt), 2012, Vol. 31, no. 1, pp. 7-19.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bhat R., Watzl C. Serial killing of tumor cells by human natural killer cells – enhancement by therapeutic antibodies. PLoS One, 2007, Vol. 2, no. 3, e326. doi: 10.1371/journal.pone.0000326.</mixed-citation><mixed-citation xml:lang="en">Bhat R., Watzl C. Serial killing of tumor cells by human natural killer cells – enhancement by therapeutic antibodies. PLoS One, 2007, Vol. 2, no. 3, e326. doi: 10.1371/journal.pone.0000326.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bin N.R., Ma K., Tien C.W., Wang S., Zhu D., Park S., Turlova E., Sugita K., Shirakawa R., van der Sluijs P., Horiuchi H., Sun H.S., Monnier P.P., Gaisano H.Y., Sugita S. C2 Domains of Munc13-4 Are Crucial for Ca(2+)-dependent degranulation and cytotoxicity in NK cells. J. Immunol., 2018, Vol. 201, no. 2, pp. 700-713.</mixed-citation><mixed-citation xml:lang="en">Bin N.R., Ma K., Tien C.W., Wang S., Zhu D., Park S., Turlova E., Sugita K., Shirakawa R., van der Sluijs P., Horiuchi H., Sun H.S., Monnier P.P., Gaisano H.Y., Sugita S. C2 Domains of Munc13-4 Are Crucial for Ca(2+)-dependent degranulation and cytotoxicity in NK cells. J. Immunol., 2018, Vol. 201, no. 2, pp. 700-713.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bonanni V., Sciume G., Santoni A., Bernardini G. Bone marrow NK cells: origin, distinctive features, and requirements for tissue localization. Front. Immunol., 2019, Vol. 10, 1569. doi: 10.3389/fimmu.2019.01569.</mixed-citation><mixed-citation xml:lang="en">Bonanni V., Sciume G., Santoni A., Bernardini G. Bone marrow NK cells: origin, distinctive features, and requirements for tissue localization. Front. Immunol., 2019, Vol. 10, 1569. doi: 10.3389/fimmu.2019.01569.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bozzano F., Perrone C., Moretta L., de Maria A. NK cell precursors in human bone marrow in health and inflammation. Front. Immunol., 2019, Vol. 10, 2045. doi: 10.3389/fimmu.2019.02045.</mixed-citation><mixed-citation xml:lang="en">Bozzano F., Perrone C., Moretta L., de Maria A. NK cell precursors in human bone marrow in health and inflammation. Front. Immunol., 2019, Vol. 10, 2045. doi: 10.3389/fimmu.2019.02045.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bulla R., Villa A., Bossi F., Cassetti A., Radillo O., Spessotto P., de Seta F., Guaschino S., Tedesco F. VEcadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp. Cell Res., 2005, Vol. 303, no. 1, pp. 101-113.</mixed-citation><mixed-citation xml:lang="en">Bulla R., Villa A., Bossi F., Cassetti A., Radillo O., Spessotto P., de Seta F., Guaschino S., Tedesco F. VEcadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp. Cell Res., 2005, Vol. 303, no. 1, pp. 101-113.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell K.S., Purdy A.K. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology, 2011, Vol. 132, no. 3, pp. 315-325.</mixed-citation><mixed-citation xml:lang="en">Campbell K.S., Purdy A.K. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology, 2011, Vol. 132, no. 3, pp. 315-325.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Carman C.V., Springer T.A. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol., 2004, Vol. 167, no. 2, pp. 377-388.</mixed-citation><mixed-citation xml:lang="en">Carman C.V., Springer T.A. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol., 2004, Vol. 167, no. 2, pp. 377-388.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cartwright J.E., Balarajah G. Trophoblast interactions with endothelial cells are increased by interleukin 1beta and tumour necrosis factor alpha and involve vascular cell adhesion molecule-1 and alpha4beta1. Exp. Cell Res., 2005, Vol. 304, no. 1, pp. 328-336.</mixed-citation><mixed-citation xml:lang="en">Cartwright J.E., Balarajah G. Trophoblast interactions with endothelial cells are increased by interleukin 1beta and tumour necrosis factor alpha and involve vascular cell adhesion molecule-1 and alpha4beta1. Exp. Cell Res., 2005, Vol. 304, no. 1, pp. 328-336.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Chitadze G., Lettau M., Bhat J., Wesch D., Steinle A., Furst D., Mytilineos J., Kalthoff H., Janssen O., Oberg H.H., Kabelitz D. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17. Int. J. Cancer, 2013, Vol. 133, no. 7, pp. 1557-1566.</mixed-citation><mixed-citation xml:lang="en">Chitadze G., Lettau M., Bhat J., Wesch D., Steinle A., Furst D., Mytilineos J., Kalthoff H., Janssen O., Oberg H.H., Kabelitz D. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17. Int. J. Cancer, 2013, Vol. 133, no. 7, pp. 1557-1566.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Cichocki F., Schlums H., Theorell J., Tesi B., Miller J.S., Ljunggren H.G., Bryceson Y.T. Diversification and functional specialization of human NK cell subsets. Curr. Top. Microbiol. Immunol., 2016, Vol. 395, pp. 63-94.</mixed-citation><mixed-citation xml:lang="en">Cichocki F., Schlums H., Theorell J., Tesi B., Miller J.S., Ljunggren H.G., Bryceson Y.T. Diversification and functional specialization of human NK cell subsets. Curr. Top. Microbiol. Immunol., 2016, Vol. 395, pp. 63-94.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Cohnen A., Chiang S.C., Stojanovic A., Schmidt H., Claus M., Saftig P., Janssen O., Cerwenka A., Bryceson Y.T., Watzl C. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood, 2013, Vol. 122, no. 8, pp. 1411-1418.</mixed-citation><mixed-citation xml:lang="en">Cohnen A., Chiang S.C., Stojanovic A., Schmidt H., Claus M., Saftig P., Janssen O., Cerwenka A., Bryceson Y.T., Watzl C. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood, 2013, Vol. 122, no. 8, pp. 1411-1418.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood, 2001, Vol. 97, no. 10, pp. 3146-3151.</mixed-citation><mixed-citation xml:lang="en">Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood, 2001, Vol. 97, no. 10, pp. 3146-3151.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cui G., Hara T., Simmons S., Wagatsuma K., Abe A., Miyachi H., Kitano S., Ishii M., Tani-ichi S., Ikuta K. Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo. Proc. Natl Acad. Sci. USA, 2014, Vol. 111, no. 5, pp. 1915-1920.</mixed-citation><mixed-citation xml:lang="en">Cui G., Hara T., Simmons S., Wagatsuma K., Abe A., Miyachi H., Kitano S., Ishii M., Tani-ichi S., Ikuta K. Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo. Proc. Natl Acad. Sci. USA, 2014, Vol. 111, no. 5, pp. 1915-1920.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Del Zotto G., Marcenaro E., Vacca P., Sivori S., Pende D., Della Chiesa M., Moretta F., Ingegnere T., Mingari M.C., Moretta A., Moretta L. Markers and function of human NK cells in normal and pathological conditions. Cytometry B Clin. Cytom., 2017, Vol. 92, no. 2, pp. 100-114.</mixed-citation><mixed-citation xml:lang="en">Del Zotto G., Marcenaro E., Vacca P., Sivori S., Pende D., Della Chiesa M., Moretta F., Ingegnere T., Mingari M.C., Moretta A., Moretta L. Markers and function of human NK cells in normal and pathological conditions. Cytometry B Clin. Cytom., 2017, Vol. 92, no. 2, pp. 100-114.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Diefenbach A., Colonna M., Romagnani C. The ILC World Revisited. Immunity, 2017, Vol. 46, no. 3, pp. 327-332.</mixed-citation><mixed-citation xml:lang="en">Diefenbach A., Colonna M., Romagnani C. The ILC World Revisited. Immunity, 2017, Vol. 46, no. 3, pp. 327-332.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dunne J.L., Collins R.G., Beaudet A.L., Ballantyne C.M.,Ley K. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J. Immunol., 2003, Vol. 171, no. 11, pp. 6105-6111.</mixed-citation><mixed-citation xml:lang="en">Dunne J.L., Collins R.G., Beaudet A.L., Ballantyne C.M.,Ley K. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J. Immunol., 2003, Vol. 171, no. 11, pp. 6105-6111.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Dustin M.L., Long E.O. Cytotoxic immunological synapses. Immunol. Rev., 2010, Vol. 235, no. 1, pp. 24-34.</mixed-citation><mixed-citation xml:lang="en">Dustin M.L., Long E.O. Cytotoxic immunological synapses. Immunol. Rev., 2010, Vol. 235, no. 1, pp. 24-34.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Elliott J.M., Wahle J.A., Yokoyama W.M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med., 2010, Vol. 207, no. 10, pp. 2073-2079.</mixed-citation><mixed-citation xml:lang="en">Elliott J.M., Wahle J.A., Yokoyama W.M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med., 2010, Vol. 207, no. 10, pp. 2073-2079.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Elstak E.D., Neeft M., Nehme N.T., Callebaut I., de Saint Basile G., van der Sluijs P. Munc13-4*rab27 complex tethers secretory lysosomes at the plasma membrane. Commun. Integr. Biol., 2012, Vol. 5, no. 1, pp. 64-67.</mixed-citation><mixed-citation xml:lang="en">Elstak E.D., Neeft M., Nehme N.T., Callebaut I., de Saint Basile G., van der Sluijs P. Munc13-4*rab27 complex tethers secretory lysosomes at the plasma membrane. Commun. Integr. Biol., 2012, Vol. 5, no. 1, pp. 64-67.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrari de Andrade L., Tay R.E., Pan D., Luoma A.M., Ito Y., Badrinath S., Tsoucas D., Franz B., May K.F., Jr., Harvey C.J., Kobold S., Pyrdol J.W., Yoon C., Yuan G.C., Hodi F.S., Dranoff G.,Wucherpfennig K.W. Antibodymediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. Science, 2018, Vol. 359, no. 6383, pp. 1537-1542.</mixed-citation><mixed-citation xml:lang="en">Ferrari de Andrade L., Tay R.E., Pan D., Luoma A.M., Ito Y., Badrinath S., Tsoucas D., Franz B., May K.F., Jr., Harvey C.J., Kobold S., Pyrdol J.W., Yoon C., Yuan G.C., Hodi F.S., Dranoff G.,Wucherpfennig K.W. Antibodymediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. Science, 2018, Vol. 359, no. 6383, pp. 1537-1542.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Foley B., Felices M., Cichocki F., Cooley S., Verneris M.R., Miller J.S. The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). Immunol. Rev., 2014, Vol. 258, no. 1, pp. 45-63.</mixed-citation><mixed-citation xml:lang="en">Foley B., Felices M., Cichocki F., Cooley S., Verneris M.R., Miller J.S. The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). Immunol. Rev., 2014, Vol. 258, no. 1, pp. 45-63.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Frangsmyr L., Baranov V., Nagaeva O., Stendahl U., Kjellberg L., Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod., 2005, Vol. 11, no. 1, pp. 35-41.</mixed-citation><mixed-citation xml:lang="en">Frangsmyr L., Baranov V., Nagaeva O., Stendahl U., Kjellberg L., Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol. Hum. Reprod., 2005, Vol. 11, no. 1, pp. 35-41.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Freud A.G., Yu J., Caligiuri M.A. Human natural killer cell development in secondary lymphoid tissues. Semin. Immunol., 2014, Vol. 26, no. 2, pp. 132-137.</mixed-citation><mixed-citation xml:lang="en">Freud A.G., Yu J., Caligiuri M.A. Human natural killer cell development in secondary lymphoid tissues. Semin. Immunol., 2014, Vol. 26, no. 2, pp. 132-137.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med., 2002, Vol. 196, no. 4, pp. 459-468.</mixed-citation><mixed-citation xml:lang="en">Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med., 2002, Vol. 196, no. 4, pp. 459-468.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Frutoso M., Mortier E. NK Cell Hyporesponsiveness: more is not always better. Int. J. Mol. Sci., 2019, Vol. 20, no. 18, 4514. doi: 10.3390/ijms20184514.</mixed-citation><mixed-citation xml:lang="en">Frutoso M., Mortier E. NK Cell Hyporesponsiveness: more is not always better. Int. J. Mol. Sci., 2019, Vol. 20, no. 18, 4514. doi: 10.3390/ijms20184514.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Fu B., Zhou Y., Ni X., Tong X., Xu X., Dong Z., Sun R., Tian Z., Wei H. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors. Immunity, 2017, Vol. 47, no. 6, pp. 1100-1113.e6.</mixed-citation><mixed-citation xml:lang="en">Fu B., Zhou Y., Ni X., Tong X., Xu X., Dong Z., Sun R., Tian Z., Wei H. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors. Immunity, 2017, Vol. 47, no. 6, pp. 1100-1113.e6.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Furuya M., Kurasawa K., Nagahama K., Kawachi K., Nozawa A., Takahashi T., Aoki I. Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J. Pregnancy, 2011, Vol. 2011, 123717. doi: 10.1155/2011/123717.</mixed-citation><mixed-citation xml:lang="en">Furuya M., Kurasawa K., Nagahama K., Kawachi K., Nozawa A., Takahashi T., Aoki I. Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J. Pregnancy, 2011, Vol. 2011, 123717. doi: 10.1155/2011/123717.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Gismondi A., Morrone S., Humphries M.J., Piccoli M., Frati L., Santoni A. Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J. Immunol., 1991, Vol. 146, no. 1, pp. 384-392.</mixed-citation><mixed-citation xml:lang="en">Gismondi A., Morrone S., Humphries M.J., Piccoli M., Frati L., Santoni A. Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J. Immunol., 1991, Vol. 146, no. 1, pp. 384-392.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Gotthardt D., Trifinopoulos J., Sexl V., Putz E.M. JAK/STAT cytokine signaling at the crossroad of NK cell development and maturation. Front. Immunol., 2019, Vol. 10, 2590. doi: 10.3389/fimmu.2019.02590.</mixed-citation><mixed-citation xml:lang="en">Gotthardt D., Trifinopoulos J., Sexl V., Putz E.M. JAK/STAT cytokine signaling at the crossroad of NK cell development and maturation. Front. Immunol., 2019, Vol. 10, 2590. doi: 10.3389/fimmu.2019.02590.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Hedlund M., Stenqvist A.C., Nagaeva O., Kjellberg L., Wulff M., Baranov V., Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol., 2009, Vol. 183, no. 1, pp. 340-351.</mixed-citation><mixed-citation xml:lang="en">Hedlund M., Stenqvist A.C., Nagaeva O., Kjellberg L., Wulff M., Baranov V., Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol., 2009, Vol. 183, no. 1, pp. 340-351.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Hiby S.E., Apps R., Sharkey A.M., Farrell L.E., Gardner L., Mulder A., Claas F.H., Walker J.J., Redman C.W., Morgan L., Tower C., Regan L., Moore G.E., Carrington M., Moffett A. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest., 2010, Vol. 120, no. 11, pp. 4102-4110.</mixed-citation><mixed-citation xml:lang="en">Hiby S.E., Apps R., Sharkey A.M., Farrell L.E., Gardner L., Mulder A., Claas F.H., Walker J.J., Redman C.W., Morgan L., Tower C., Regan L., Moore G.E., Carrington M., Moffett A. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest., 2010, Vol. 120, no. 11, pp. 4102-4110.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Hiebert P.R., Granville D.J. Granzyme B in injury, inflammation, and repair. Trends Mol. Med., 2012, Vol. 18, no. 12, pp. 732-41.</mixed-citation><mixed-citation xml:lang="en">Hiebert P.R., Granville D.J. Granzyme B in injury, inflammation, and repair. Trends Mol. Med., 2012, Vol. 18, no. 12, pp. 732-41.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Ikeda H., Old L.J., Schreiber R.D. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev., 2002, Vol. 13, no. 2, pp. 95-109.</mixed-citation><mixed-citation xml:lang="en">Ikeda H., Old L.J., Schreiber R.D. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev., 2002, Vol. 13, no. 2, pp. 95-109.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Kang X., Kim J., Deng M., John S., Chen H., Wu G., Phan H., Zhang C.C. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors. Cell Cycle, 2016, Vol. 15, no. 1, pp. 25-40.</mixed-citation><mixed-citation xml:lang="en">Kang X., Kim J., Deng M., John S., Chen H., Wu G., Phan H., Zhang C.C. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors. Cell Cycle, 2016, Vol. 15, no. 1, pp. 25-40.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Konjevic G.M., Vuletic A.M., Mirjacic Martinovic K.M., Larsen A.K., Jurisic V.B. The role of cytokines in the regulation of NK cells in the tumor environment. Cytokine, 2019, Vol. 117, pp. 30-40.</mixed-citation><mixed-citation xml:lang="en">Konjevic G.M., Vuletic A.M., Mirjacic Martinovic K.M., Larsen A.K., Jurisic V.B. The role of cytokines in the regulation of NK cells in the tumor environment. Cytokine, 2019, Vol. 117, pp. 30-40.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Krzewski K., Strominger J.L. The killer’s kiss: the many functions of NK cell immunological synapses. Curr. Opin. Cell Biol., 2008, Vol. 20, no. 5, pp. 597-605.</mixed-citation><mixed-citation xml:lang="en">Krzewski K., Strominger J.L. The killer’s kiss: the many functions of NK cell immunological synapses. Curr. Opin. Cell Biol., 2008, Vol. 20, no. 5, pp. 597-605.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar S. Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology, 2018, Vol. 154, no. 3, pp. 383-393.</mixed-citation><mixed-citation xml:lang="en">Kumar S. Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology, 2018, Vol. 154, no. 3, pp. 383-393.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Lagrue K., Carisey A., Oszmiana A., Kennedy P.R., Williamson D.J., Cartwright A., Barthen C., Davis D.M. The central role of the cytoskeleton in mechanisms and functions of the NK cell immune synapse. Immunol. Rev., 2013, Vol. 256, no. 1, pp. 203-221.</mixed-citation><mixed-citation xml:lang="en">Lagrue K., Carisey A., Oszmiana A., Kennedy P.R., Williamson D.J., Cartwright A., Barthen C., Davis D.M. The central role of the cytoskeleton in mechanisms and functions of the NK cell immune synapse. Immunol. Rev., 2013, Vol. 256, no. 1, pp. 203-221.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Lanier L.L. NKG2D Receptor and its ligands in host defense. Cancer Immunol. Res., 2015, Vol. 3, no. 6, pp. 575-582.</mixed-citation><mixed-citation xml:lang="en">Lanier L.L. NKG2D Receptor and its ligands in host defense. Cancer Immunol. Res., 2015, Vol. 3, no. 6, pp. 575-582.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Lanier L.L., Yu G., Phillips J.H. Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J. Immunol., 1991, Vol. 146, no. 5, pp. 1571-1576.</mixed-citation><mixed-citation xml:lang="en">Lanier L.L., Yu G., Phillips J.H. Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J. Immunol., 1991, Vol. 146, no. 5, pp. 1571-1576.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Lanier L.L., Yu G., Phillips J.H. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature, 1989, Vol. 342, no. 6251, pp. 803-805.</mixed-citation><mixed-citation xml:lang="en">Lanier L.L., Yu G., Phillips J.H. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature, 1989, Vol. 342, no. 6251, pp. 803-805.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol., 1996, Vol. 157, no. 11, pp. 4741-4745.</mixed-citation><mixed-citation xml:lang="en">Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol., 1996, Vol. 157, no. 11, pp. 4741-4745.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Lee C.C., Avalos A.M., Ploegh H.L. Accessory molecules for Toll-like receptors and their function. Nat. Rev. Immunol., 2012, Vol. 12, no. 3, pp. 168-179.</mixed-citation><mixed-citation xml:lang="en">Lee C.C., Avalos A.M., Ploegh H.L. Accessory molecules for Toll-like receptors and their function. Nat. Rev. Immunol., 2012, Vol. 12, no. 3, pp. 168-179.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Li Z., Deng M., Huang F., Jin C., Sun S., Chen H., Liu X., He L., Sadek A.H., Zhang C.C. LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells. Cell. Mol. Immunol., 2020, Vol. 17, no. 3, pp. 272-282.</mixed-citation><mixed-citation xml:lang="en">Li Z., Deng M., Huang F., Jin C., Sun S., Chen H., Liu X., He L., Sadek A.H., Zhang C.C. LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells. Cell. Mol. Immunol., 2020, Vol. 17, no. 3, pp. 272-282.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Linhares-Lacerda L., Ribeiro-Alves M., Nogueira A.C., Mendes-da-Cruz D.A., Magalhaes D.A., Dardenne M., Passos G.A., Savino W. RNA interference-mediated knockdown of CD49e (alpha5 integrin chain) in human thymic epithelial cells modulates the expression of multiple genes and decreases thymocyte adhesion. BMC Genomics, 2010, Vol. 11, Suppl. 5, S2. doi: 10.1186/1471-2164-11-S5-S2.</mixed-citation><mixed-citation xml:lang="en">Linhares-Lacerda L., Ribeiro-Alves M., Nogueira A.C., Mendes-da-Cruz D.A., Magalhaes D.A., Dardenne M., Passos G.A., Savino W. RNA interference-mediated knockdown of CD49e (alpha5 integrin chain) in human thymic epithelial cells modulates the expression of multiple genes and decreases thymocyte adhesion. BMC Genomics, 2010, Vol. 11, Suppl. 5, S2. doi: 10.1186/1471-2164-11-S5-S2.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S., Zhang H., Li M., Hu D., Li C., Ge B., Jin B., Fan Z. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ., 2013, Vol. 20, no. 3, pp. 456-464.</mixed-citation><mixed-citation xml:lang="en">Liu S., Zhang H., Li M., Hu D., Li C., Ge B., Jin B., Fan Z. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ., 2013, Vol. 20, no. 3, pp. 456-464.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X.T., Sun H.T., Zhang Z.F., Shi R.X., Liu L.B., Yu J.J., Zhou W.J., Gu C.J., Yang S.L., Liu Y.K., Yang H.L., Xu F.X., Li M.Q. Indoleamine 2,3-dioxygenase suppresses the cytotoxicity of 1 NK cells in response to ectopicendometrial stromal cells in endometriosis. Reproduction, 2018, Vol. 156, no. 5, pp. 397-404.</mixed-citation><mixed-citation xml:lang="en">Liu X.T., Sun H.T., Zhang Z.F., Shi R.X., Liu L.B., Yu J.J., Zhou W.J., Gu C.J., Yang S.L., Liu Y.K., Yang H.L., Xu F.X., Li M.Q. Indoleamine 2,3-dioxygenase suppresses the cytotoxicity of 1 NK cells in response to ectopicendometrial stromal cells in endometriosis. Reproduction, 2018, Vol. 156, no. 5, pp. 397-404.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez J.A., Susanto O., Jenkins M.R., Lukoyanova N., Sutton V.R., Law R.H., Johnston A., Bird C.H., Bird P.I., Whisstock J.C., Trapani J.A., Saibil H.R., Voskoboinik I. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood, 2013, Vol. 121, no. 14, pp. 2659-2668.</mixed-citation><mixed-citation xml:lang="en">Lopez J.A., Susanto O., Jenkins M.R., Lukoyanova N., Sutton V.R., Law R.H., Johnston A., Bird C.H., Bird P.I., Whisstock J.C., Trapani J.A., Saibil H.R., Voskoboinik I. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood, 2013, Vol. 121, no. 14, pp. 2659-2668.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Lu L., Zhang A.Y., Camp W.L., Qian S. Natural killer cell induction of tolerance. In book: natural killer cells. Basic science and clinical application. Academic Press, 2010, pp. 617-631.</mixed-citation><mixed-citation xml:lang="en">Lu L., Zhang A.Y., Camp W.L., Qian S. Natural killer cell induction of tolerance. In book: natural killer cells. Basic science and clinical application. Academic Press, 2010, pp. 617-631.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Mace E.M., Dongre P., Hsu H.T., Sinha P., James A.M., Mann S.S., Forbes L.R., Watkin L.B., Orange J.S. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol. Cell Biol., 2014, Vol. 92, no. 3, pp. 245-255.</mixed-citation><mixed-citation xml:lang="en">Mace E.M., Dongre P., Hsu H.T., Sinha P., James A.M., Mann S.S., Forbes L.R., Watkin L.B., Orange J.S. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol. Cell Biol., 2014, Vol. 92, no. 3, pp. 245-255.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Maghazachi A.A. Role of chemokines in the biology of natural killer cells. Curr. Top. Microbiol. Immunol., 2010, Vol. 341, pp. 37-58.</mixed-citation><mixed-citation xml:lang="en">Maghazachi A.A. Role of chemokines in the biology of natural killer cells. Curr. Top. Microbiol. Immunol., 2010, Vol. 341, pp. 37-58.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature, 2001, Vol. 409, no. 6823, pp. 1055-1060.</mixed-citation><mixed-citation xml:lang="en">Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature, 2001, Vol. 409, no. 6823, pp. 1055-1060.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Mariuzza R.A., Agnihotri P., Orban J. The structural basis of T-cell receptor (TCR) activation: An enduring enigma. J. Biol. Chem., 2020, Vol. 295, no. 4, pp. 914-925.</mixed-citation><mixed-citation xml:lang="en">Mariuzza R.A., Agnihotri P., Orban J. The structural basis of T-cell receptor (TCR) activation: An enduring enigma. J. Biol. Chem., 2020, Vol. 295, no. 4, pp. 914-925.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Matesanz-Isabel J., Sintes J., Llinas L., de Salort J., Lazaro A., Engel P. New B-cell CD molecules. Immunol. Lett., 2011, Vol. 134, no. 2, pp. 104-112.</mixed-citation><mixed-citation xml:lang="en">Matesanz-Isabel J., Sintes J., Llinas L., de Salort J., Lazaro A., Engel P. New B-cell CD molecules. Immunol. Lett., 2011, Vol. 134, no. 2, pp. 104-112.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Mattiola I., Pesant M., Tentorio P.F., Molgora M., Marcenaro E., Lugli E., Locati M., Mavilio D. Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways. J. Immunol., 2015, Vol. 195, no. 6, pp. 2818-2828.</mixed-citation><mixed-citation xml:lang="en">Mattiola I., Pesant M., Tentorio P.F., Molgora M., Marcenaro E., Lugli E., Locati M., Mavilio D. Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways. J. Immunol., 2015, Vol. 195, no. 6, pp. 2818-2828.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">McCann F.E., Vanherberghen B., Eleme K., Carlin L.M., Newsam R.J., Goulding D., Davis D.M. The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J. Immunol., 2003, Vol. 170, no. 6, pp. 2862-2870.</mixed-citation><mixed-citation xml:lang="en">McCann F.E., Vanherberghen B., Eleme K., Carlin L.M., Newsam R.J., Goulding D., Davis D.M. The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J. Immunol., 2003, Vol. 170, no. 6, pp. 2862-2870.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">McQuaid A., Tormey V.J., Trafford B., Webster A.D., Bofill M. Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency. Clin. Exp. Immunol., 2003, Vol. 134, no. 2, pp. 321-327.</mixed-citation><mixed-citation xml:lang="en">McQuaid A., Tormey V.J., Trafford B., Webster A.D., Bofill M. Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency. Clin. Exp. Immunol., 2003, Vol. 134, no. 2, pp. 321-327.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Mei B., Zhang S.R., Chen Y.L., Wang C.F. Defects in NKG2D ligand expression result in failed tolerance induction at the maternal-fetal interface: a possible cause for recurrent miscarriage. Med. Hypotheses, 2012, Vol. 79, no. 4, pp. 465-467.</mixed-citation><mixed-citation xml:lang="en">Mei B., Zhang S.R., Chen Y.L., Wang C.F. Defects in NKG2D ligand expression result in failed tolerance induction at the maternal-fetal interface: a possible cause for recurrent miscarriage. Med. Hypotheses, 2012, Vol. 79, no. 4, pp. 465-467.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Meniailo M.E., Malashchenko V.V., Shmarov V.A., Gazatova N.D., Melashchenko O.B., Goncharov A.G., Seledtsova G.V., Seledtsov V.I. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int. Immunopharmacol., 2017, Vol. 50, pp. 178-185.</mixed-citation><mixed-citation xml:lang="en">Meniailo M.E., Malashchenko V.V., Shmarov V.A., Gazatova N.D., Melashchenko O.B., Goncharov A.G., Seledtsova G.V., Seledtsov V.I. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int. Immunopharmacol., 2017, Vol. 50, pp. 178-185.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Metkar S.S., Wang B., Aguilar-Santelises M., Raja S.M., Uhlin-Hansen L., Podack E., Trapani J.A., Froelich C.J. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity, 2002, Vol. 16, no. 3, pp. 417-428.</mixed-citation><mixed-citation xml:lang="en">Metkar S.S., Wang B., Aguilar-Santelises M., Raja S.M., Uhlin-Hansen L., Podack E., Trapani J.A., Froelich C.J. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity, 2002, Vol. 16, no. 3, pp. 417-428.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Meza Guzman L.G., Keating N., Nicholson S.E. Natural killer cells: tumor surveillance and signaling. Cancers (Basel), 2020, Vol. 12, no. 4, 952. doi: 10.3390/cancers12040952.</mixed-citation><mixed-citation xml:lang="en">Meza Guzman L.G., Keating N., Nicholson S.E. Natural killer cells: tumor surveillance and signaling. Cancers (Basel), 2020, Vol. 12, no. 4, 952. doi: 10.3390/cancers12040952.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Mihara M., Hashizume M., Yoshida H., Suzuki M., Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.), 2012, Vol. 122, no. 4, pp. 143-159.</mixed-citation><mixed-citation xml:lang="en">Mihara M., Hashizume M., Yoshida H., Suzuki M., Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.), 2012, Vol. 122, no. 4, pp. 143-159.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Mikhailova V.A., Bazhenov D.O., Belyakova K.L., Selkov S.A., Sokolov D.I. Differentiation of NK cells. A look through the prism of transcription factors and intercellular messengers. Medical Immunology (Russia), 2019, Vol. 21, no. 1, pp. 21-38. doi: 10.15789/1563-0625-2019-1-21-38.</mixed-citation><mixed-citation xml:lang="en">Mikhailova V.A., Bazhenov D.O., Belyakova K.L., Selkov S.A., Sokolov D.I. Differentiation of NK cells. A look through the prism of transcription factors and intercellular messengers. Medical Immunology (Russia), 2019, Vol. 21, no. 1, pp. 21-38. doi: 10.15789/1563-0625-2019-1-21-38.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Mikhailova V.A., Belyakova K.L., Selkov S.A., Sokolov D.I. Peculiarities of NK cells differentiation: CD56dim and CD56bright NK cells at pregnancy and in non-pregnant state. Medical Immunology (Russia), 2017, Vol. 19, no. 1, pp. 19-26. doi: 10.15789/1563-0625-2017-1-19-26.</mixed-citation><mixed-citation xml:lang="en">Mikhailova V.A., Belyakova K.L., Selkov S.A., Sokolov D.I. Peculiarities of NK cells differentiation: CD56dim and CD56bright NK cells at pregnancy and in non-pregnant state. Medical Immunology (Russia), 2017, Vol. 19, no. 1, pp. 19-26. doi: 10.15789/1563-0625-2017-1-19-26.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Mincheva-Nilsson L., Baranov V. Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance. Semin. Cancer Biol., 2014, Vol. 28, pp. 24-30.</mixed-citation><mixed-citation xml:lang="en">Mincheva-Nilsson L., Baranov V. Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance. Semin. Cancer Biol., 2014, Vol. 28, pp. 24-30.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Moffett A., Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J. Clin. Invest., 2014, Vol. 124, no. 5, pp. 1872-1879.</mixed-citation><mixed-citation xml:lang="en">Moffett A., Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J. Clin. Invest., 2014, Vol. 124, no. 5, pp. 1872-1879.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Moniuszko M., Kowal K., Jeznach M., Rusak M., Dabrowska M., Bodzenta-Lukaszyk A. Phenotypic correlations between monocytes and CD4+ T cells in allergic patients. Int. Arch. Allergy Immunol., 2013, Vol. 161, no. 2, pp. 131-141.</mixed-citation><mixed-citation xml:lang="en">Moniuszko M., Kowal K., Jeznach M., Rusak M., Dabrowska M., Bodzenta-Lukaszyk A. Phenotypic correlations between monocytes and CD4+ T cells in allergic patients. Int. Arch. Allergy Immunol., 2013, Vol. 161, no. 2, pp. 131-141.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Montaldo E., Del Zotto G., Della Chiesa M., Mingari M.C., Moretta A., De Maria A., Moretta L. Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A, 2013, Vol. 83, no. 8, pp. 702-713.</mixed-citation><mixed-citation xml:lang="en">Montaldo E., Del Zotto G., Della Chiesa M., Mingari M.C., Moretta A., De Maria A., Moretta L. Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A, 2013, Vol. 83, no. 8, pp. 702-713.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Montaldo E., Vitale C., Cottalasso F., Conte R., Glatzer T., Ambrosini P., Moretta L., Mingari M.C. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood, 2012, Vol. 119, no. 17, pp. 3987-3996.</mixed-citation><mixed-citation xml:lang="en">Montaldo E., Vitale C., Cottalasso F., Conte R., Glatzer T., Ambrosini P., Moretta L., Mingari M.C. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood, 2012, Vol. 119, no. 17, pp. 3987-3996.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol., 2001, Vol. 19, pp. 197-223.</mixed-citation><mixed-citation xml:lang="en">Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol., 2001, Vol. 19, pp. 197-223.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Netter P., Anft M., Watzl C. Termination of the activating NK cell immunological synapse is an active and regulated process. J. Immunol., 2017, Vol. 199, no. 7, pp. 2528-2535.</mixed-citation><mixed-citation xml:lang="en">Netter P., Anft M., Watzl C. Termination of the activating NK cell immunological synapse is an active and regulated process. J. Immunol., 2017, Vol. 199, no. 7, pp. 2528-2535.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Nieto M., Navarro F., Perez-Villar J.J., del Pozo M.A., Gonzalez-Amaro R., Mellado M., Frade J.M., Martinez A.C., Lopez-Botet M., Sanchez-Madrid F. Roles of chemokines and receptor polarization in NK-target cell interactions. J. Immunol., 1998, Vol. 161, no. 7, pp. 3330-3339.</mixed-citation><mixed-citation xml:lang="en">Nieto M., Navarro F., Perez-Villar J.J., del Pozo M.A., Gonzalez-Amaro R., Mellado M., Frade J.M., Martinez A.C., Lopez-Botet M., Sanchez-Madrid F. Roles of chemokines and receptor polarization in NK-target cell interactions. J. Immunol., 1998, Vol. 161, no. 7, pp. 3330-3339.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Nowak I., Wilczynska K., Wilczynski J.R., Malinowski A., Radwan P., Radwan M., Kusnierczyk P. KIR, LILRB and their Ligands’ Genes as Potential Biomarkers in Recurrent Implantation Failure. Arch. Immunol. Ther. Exp. (Warsz), 2017, Vol. 65, no. 5, pp. 391-399.</mixed-citation><mixed-citation xml:lang="en">Nowak I., Wilczynska K., Wilczynski J.R., Malinowski A., Radwan P., Radwan M., Kusnierczyk P. KIR, LILRB and their Ligands’ Genes as Potential Biomarkers in Recurrent Implantation Failure. Arch. Immunol. Ther. Exp. (Warsz), 2017, Vol. 65, no. 5, pp. 391-399.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">O’Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol., 2006, Vol. 7, no. 5, pp. 507-516.</mixed-citation><mixed-citation xml:lang="en">O’Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol., 2006, Vol. 7, no. 5, pp. 507-516.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Orange J.S. Formation and function of the lytic NK-cell immunological synapse. Nat. Rev. Immunol., 2008, Vol. 8, no. 9, pp. 713-725.</mixed-citation><mixed-citation xml:lang="en">Orange J.S. Formation and function of the lytic NK-cell immunological synapse. Nat. Rev. Immunol., 2008, Vol. 8, no. 9, pp. 713-725.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Orange J.S., Harris K.E., Andzelm M.M., Valter M.M., Geha R.S., Strominger J.L. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc. Natl Acad. Sci. USA, 2003, Vol. 100, no. 24, pp. 14151-14156.</mixed-citation><mixed-citation xml:lang="en">Orange J.S., Harris K.E., Andzelm M.M., Valter M.M., Geha R.S., Strominger J.L. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc. Natl Acad. Sci. USA, 2003, Vol. 100, no. 24, pp. 14151-14156.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Orange J.S., Ramesh N., Remold-O’Donnell E., Sasahara Y., Koopman L., Byrne M., Bonilla F.A., Rosen F.S., Geha R.S., Strominger J.L. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc. Natl Acad. Sci. USA, 2002, Vol. 99, no. 17, pp. 11351-11356.</mixed-citation><mixed-citation xml:lang="en">Orange J.S., Ramesh N., Remold-O’Donnell E., Sasahara Y., Koopman L., Byrne M., Bonilla F.A., Rosen F.S., Geha R.S., Strominger J.L. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc. Natl Acad. Sci. USA, 2002, Vol. 99, no. 17, pp. 11351-11356.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Pahl J.H.W., Cerwenka A., Ni J. Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors. Front. Immunol., 2018, Vol. 9, 2796. doi: 10.3389/fimmu.2018.02796.</mixed-citation><mixed-citation xml:lang="en">Pahl J.H.W., Cerwenka A., Ni J. Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors. Front. Immunol., 2018, Vol. 9, 2796. doi: 10.3389/fimmu.2018.02796.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L., Moretta A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med., 1999, Vol. 190, no. 10, pp. 1505-1516.</mixed-citation><mixed-citation xml:lang="en">Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L., Moretta A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med., 1999, Vol. 190, no. 10, pp. 1505-1516.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Phatarpekar P.V., Billadeau D.D. Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function. J. Cell Sci., 2020, Vol. 133, no. 5, jcs240424. doi: 10.1242/jcs.240424.</mixed-citation><mixed-citation xml:lang="en">Phatarpekar P.V., Billadeau D.D. Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function. J. Cell Sci., 2020, Vol. 133, no. 5, jcs240424. doi: 10.1242/jcs.240424.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Pollheimer J., Vondra S., Baltayeva J., Beristain A.G., Knofler M. Regulation of placental extravillous trophoblasts by the maternal uterine environment. Front. Immunol., 2018, Vol. 9, 2597. doi: 10.3389/fimmu.2018.02597.</mixed-citation><mixed-citation xml:lang="en">Pollheimer J., Vondra S., Baltayeva J., Beristain A.G., Knofler M. Regulation of placental extravillous trophoblasts by the maternal uterine environment. Front. Immunol., 2018, Vol. 9, 2597. doi: 10.3389/fimmu.2018.02597.</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Prager I., Watzl C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J. Leukoc. Biol., 2019, Vol. 105, no. 6, pp. 1319-1329.</mixed-citation><mixed-citation xml:lang="en">Prager I., Watzl C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J. Leukoc. Biol., 2019, Vol. 105, no. 6, pp. 1319-1329.</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Qu X., Tang Y., Hua S. Immunological approaches towards cancer and inflammation: a cross talk. Front. Immunol., 2018, Vol. 9, 563. doi: 10.3389/fimmu.2018.00563.</mixed-citation><mixed-citation xml:lang="en">Qu X., Tang Y., Hua S. Immunological approaches towards cancer and inflammation: a cross talk. Front. Immunol., 2018, Vol. 9, 563. doi: 10.3389/fimmu.2018.00563.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Rajagopalan S., Long E.O. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front. Immunol., 2012, Vol. 3, 258. doi: 10.3389/fimmu.2012.00258.</mixed-citation><mixed-citation xml:lang="en">Rajagopalan S., Long E.O. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front. Immunol., 2012, Vol. 3, 258. doi: 10.3389/fimmu.2012.00258.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Rajashekhar G., Loganath A., Roy A.C., Chong S.S., Wong Y.C. Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J. Soc. Gynecol. Investig., 2005, Vol. 12, no. 5, pp. 310-319.</mixed-citation><mixed-citation xml:lang="en">Rajashekhar G., Loganath A., Roy A.C., Chong S.S., Wong Y.C. Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J. Soc. Gynecol. Investig., 2005, Vol. 12, no. 5, pp. 310-319.</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Rebuli M.E., Pawlak E.A., Walsh D., Martin E.M., Jaspers I. Distinguishing human peripheral blood NK cells from CD56(dim)CD16(dim)CD69(+)CD103(+) resident nasal mucosal lavage fluid cells. Sci. Rep., 2018, Vol. 8, no. 1, 3394. doi: 10.1038/s41598-018-21443-5.</mixed-citation><mixed-citation xml:lang="en">Rebuli M.E., Pawlak E.A., Walsh D., Martin E.M., Jaspers I. Distinguishing human peripheral blood NK cells from CD56(dim)CD16(dim)CD69(+)CD103(+) resident nasal mucosal lavage fluid cells. Sci. Rep., 2018, Vol. 8, no. 1, 3394. doi: 10.1038/s41598-018-21443-5.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Regis S., Dondero A., Caliendo F., Bottino C., Castriconi R. NK cell function regulation by TGF-betainduced epigenetic mechanisms. Front. Immunol., 2020, Vol. 11, 311. doi: 10.3389/fimmu.2020.00311.</mixed-citation><mixed-citation xml:lang="en">Regis S., Dondero A., Caliendo F., Bottino C., Castriconi R. NK cell function regulation by TGF-betainduced epigenetic mechanisms. Front. Immunol., 2020, Vol. 11, 311. doi: 10.3389/fimmu.2020.00311.</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Renoux V.M., Zriwil A., Peitzsch C., Michaelsson J., Friberg D., Soneji S., Sitnicka E. Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues. Immunity, 2015, Vol. 43, no. 2, pp. 394-407.</mixed-citation><mixed-citation xml:lang="en">Renoux V.M., Zriwil A., Peitzsch C., Michaelsson J., Friberg D., Soneji S., Sitnicka E. Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues. Immunity, 2015, Vol. 43, no. 2, pp. 394-407.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Romee R., Schneider S.E., Leong J.W., Chase J.M., Keppel C.R., Sullivan R.P., Cooper M.A., Fehniger T.A. Cytokine activation induces human memory-like NK cells. Blood, 2012, Vol. 120, no. 24, pp. 4751-4760.</mixed-citation><mixed-citation xml:lang="en">Romee R., Schneider S.E., Leong J.W., Chase J.M., Keppel C.R., Sullivan R.P., Cooper M.A., Fehniger T.A. Cytokine activation induces human memory-like NK cells. Blood, 2012, Vol. 120, no. 24, pp. 4751-4760.</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Rousalova I., Krepela E. Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int. J. Oncol., 2010, Vol. 37, no. 6, pp. 1361-1378.</mixed-citation><mixed-citation xml:lang="en">Rousalova I., Krepela E. Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int. J. Oncol., 2010, Vol. 37, no. 6, pp. 1361-1378.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez-Correa B., Valhondo I., Hassouneh F., Lopez-Sejas N., Pera A., Bergua J.M., Arcos M.J., Banas H., Casas-Aviles I., Duran E., Alonso C., Solana R., Tarazona R. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: novel immune checkpoints for natural killer cell-based cancer immunotherapy. Cancers (Basel), 2019, Vol. 11, no. 6, 877. doi: 10.3390/cancers11060877.</mixed-citation><mixed-citation xml:lang="en">Sanchez-Correa B., Valhondo I., Hassouneh F., Lopez-Sejas N., Pera A., Bergua J.M., Arcos M.J., Banas H., Casas-Aviles I., Duran E., Alonso C., Solana R., Tarazona R. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: novel immune checkpoints for natural killer cell-based cancer immunotherapy. Cancers (Basel), 2019, Vol. 11, no. 6, 877. doi: 10.3390/cancers11060877.</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Schleinitz N., March M.E., Long E.O. Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One, 2008, Vol. 3, no. 9, e3278. doi: 10.1371/journal.pone.0003278.</mixed-citation><mixed-citation xml:lang="en">Schleinitz N., March M.E., Long E.O. Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One, 2008, Vol. 3, no. 9, e3278. doi: 10.1371/journal.pone.0003278.</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Sivori S., Vacca P., Del Zotto G., Munari E., Mingari M.C., Moretta L. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell. Mol. Immunol., 2019, Vol. 16, no. 5, pp. 430-441.</mixed-citation><mixed-citation xml:lang="en">Sivori S., Vacca P., Del Zotto G., Munari E., Mingari M.C., Moretta L. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell. Mol. Immunol., 2019, Vol. 16, no. 5, pp. 430-441.</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Sokolov D.I., Markova K.L., Mikhailova V.A., Vyazmina L.P., Milyutina Y.P., Kozyreva A.R., Zhdanova A.A., Malygina D.A., Onokhin K.V., Ivanova A.N., Korenevsky A.V., Selkov S.A. Phenotypic and functional characteristics of microvesicles produced by natural killer cells. Medical Immunology (Russia), 2019, Vol. 21, no. 4, pp. 669-688. doi: 10.15789/1563-0625-2019-4-669-688.</mixed-citation><mixed-citation xml:lang="en">Sokolov D.I., Markova K.L., Mikhailova V.A., Vyazmina L.P., Milyutina Y.P., Kozyreva A.R., Zhdanova A.A., Malygina D.A., Onokhin K.V., Ivanova A.N., Korenevsky A.V., Selkov S.A. Phenotypic and functional characteristics of microvesicles produced by natural killer cells. Medical Immunology (Russia), 2019, Vol. 21, no. 4, pp. 669-688. doi: 10.15789/1563-0625-2019-4-669-688.</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Stenqvist A.C., Nagaeva O., Baranov V., Mincheva-Nilsson L. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosomemediated immune privilege of the fetus. J. Immunol., 2013, Vol. 191, no. 11, pp. 5515-5523.</mixed-citation><mixed-citation xml:lang="en">Stenqvist A.C., Nagaeva O., Baranov V., Mincheva-Nilsson L. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosomemediated immune privilege of the fetus. J. Immunol., 2013, Vol. 191, no. 11, pp. 5515-5523.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Stojanovic A., Correia M.P.,Cerwenka A. Shaping of NK cell responses by the tumor microenvironment. Cancer Microenviron., 2013, Vol. 6, no. 2, pp. 135-146.</mixed-citation><mixed-citation xml:lang="en">Stojanovic A., Correia M.P.,Cerwenka A. Shaping of NK cell responses by the tumor microenvironment. Cancer Microenviron., 2013, Vol. 6, no. 2, pp. 135-146.</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Suarez-Fueyo A., Bradley S.J., Katsuyama T., Solomon S., Katsuyama E., Kyttaris V.C., Moulton V.R., Tsokos G.C. Downregulation of CD3zeta in NK cells from systemic lupus erythematosus patients confers a proinflammatory phenotype. J. Immunol., 2018, Vol. 200, no. 9, pp. 3077-3086.</mixed-citation><mixed-citation xml:lang="en">Suarez-Fueyo A., Bradley S.J., Katsuyama T., Solomon S., Katsuyama E., Kyttaris V.C., Moulton V.R., Tsokos G.C. Downregulation of CD3zeta in NK cells from systemic lupus erythematosus patients confers a proinflammatory phenotype. J. Immunol., 2018, Vol. 200, no. 9, pp. 3077-3086.</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Sun H., Sun C., Xiao W. Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations. Cytokine, 2014, Vol. 65, no. 1, pp. 33-41.</mixed-citation><mixed-citation xml:lang="en">Sun H., Sun C., Xiao W. Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations. Cytokine, 2014, Vol. 65, no. 1, pp. 33-41.</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi H., Yamamoto T., Yamazaki M., Murase T., Matsuno T., Chishima F. Natural cytotoxicity receptors in decidua natural killer cells of term normal pregnancy. J. Pregnancy, 2018, Vol. 2018, 4382084. doi: 10.1155/2018/4382084.</mixed-citation><mixed-citation xml:lang="en">Takahashi H., Yamamoto T., Yamazaki M., Murase T., Matsuno T., Chishima F. Natural cytotoxicity receptors in decidua natural killer cells of term normal pregnancy. J. Pregnancy, 2018, Vol. 2018, 4382084. doi: 10.1155/2018/4382084.</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol., 2003, Vol. 21, pp. 335-376</mixed-citation><mixed-citation xml:lang="en">Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol., 2003, Vol. 21, pp. 335-376</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas L.M., Peterson M.E., Long E.O. Cutting edge: NK cell licensing modulates adhesion to target cells. J. Immunol., 2013, Vol. 191, no. 8, pp. 3981-3985.</mixed-citation><mixed-citation xml:lang="en">Thomas L.M., Peterson M.E., Long E.O. Cutting edge: NK cell licensing modulates adhesion to target cells. J. Immunol., 2013, Vol. 191, no. 8, pp. 3981-3985.</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Tufa D.M., Ahmad F., Chatterjee D., Ahrenstorf G., Schmidt R.E., Jacobs R. IL-1beta limits the extent of human 6-sulfo LacNAc dendritic cell (slanDC)-mediated NK cell activation and regulates CD95-induced apoptosis. Cell. Mol. Immunol., 2017, Vol. 14, no. 12, pp. 976-985.</mixed-citation><mixed-citation xml:lang="en">Tufa D.M., Ahmad F., Chatterjee D., Ahrenstorf G., Schmidt R.E., Jacobs R. IL-1beta limits the extent of human 6-sulfo LacNAc dendritic cell (slanDC)-mediated NK cell activation and regulates CD95-induced apoptosis. Cell. Mol. Immunol., 2017, Vol. 14, no. 12, pp. 976-985.</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Urlaub D., Hofer K., Muller M.L.,Watzl C. LFA-1 Activation in NK Cells and their subsets: influence of receptors, maturation, and cytokine stimulation. J. Immunol., 2017, Vol. 198, no. 5, pp. 1944-1951.</mixed-citation><mixed-citation xml:lang="en">Urlaub D., Hofer K., Muller M.L.,Watzl C. LFA-1 Activation in NK Cells and their subsets: influence of receptors, maturation, and cytokine stimulation. J. Immunol., 2017, Vol. 198, no. 5, pp. 1944-1951.</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Vacca P., Vitale C., Montaldo E., Conte R., Cantoni C., Fulcheri E., Darretta V., Moretta L., Mingari M.C. CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc. Natl. Acad. Sci. USA, 2011, Vol. 108, no. 6, pp. 2402-2407.</mixed-citation><mixed-citation xml:lang="en">Vacca P., Vitale C., Montaldo E., Conte R., Cantoni C., Fulcheri E., Darretta V., Moretta L., Mingari M.C. CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc. Natl. Acad. Sci. USA, 2011, Vol. 108, no. 6, pp. 2402-2407.</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">van Buul J.D., Mul F.P., van der Schoot C.E., Hordijk P.L. ICAM-3 activation modulates cell-cell contacts of human bone marrow endothelial cells. J. Vasc. Res., 2004, Vol. 41, no. 1, pp. 28-37.</mixed-citation><mixed-citation xml:lang="en">van Buul J.D., Mul F.P., van der Schoot C.E., Hordijk P.L. ICAM-3 activation modulates cell-cell contacts of human bone marrow endothelial cells. J. Vasc. Res., 2004, Vol. 41, no. 1, pp. 28-37.</mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">van der Haar Avila I., Marmol P., Cany J., Kiessling R., Pico de Coana Y. Evaluating antibody-dependent cell-mediated cytotoxicity by flow cytometry. Methods Mol. Biol., 2019, Vol. 1913, pp. 181-194.</mixed-citation><mixed-citation xml:lang="en">van der Haar Avila I., Marmol P., Cany J., Kiessling R., Pico de Coana Y. Evaluating antibody-dependent cell-mediated cytotoxicity by flow cytometry. Methods Mol. Biol., 2019, Vol. 1913, pp. 181-194.</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru">van Horssen R., Ten Hagen T.L., Eggermont A.M. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist, 2006, Vol. 11, no. 4, pp. 397-408.</mixed-citation><mixed-citation xml:lang="en">van Horssen R., Ten Hagen T.L., Eggermont A.M. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist, 2006, Vol. 11, no. 4, pp. 397-408.</mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Voloshin T., Alishekevitz D., Kaneti L., Miller V., Isakov E., Kaplanov I., Voronov E., Fremder E., Benhar M., Machluf M., Apte R.N., Shaked Y. Blocking IL1beta pathway following paclitaxel chemotherapy slightly inhibits primary tumor growth but promotes spontaneous metastasis. Mol. Cancer Ther., 2015, Vol. 14, no. 6, pp. 1385-1394.</mixed-citation><mixed-citation xml:lang="en">Voloshin T., Alishekevitz D., Kaneti L., Miller V., Isakov E., Kaplanov I., Voronov E., Fremder E., Benhar M., Machluf M., Apte R.N., Shaked Y. Blocking IL1beta pathway following paclitaxel chemotherapy slightly inhibits primary tumor growth but promotes spontaneous metastasis. Mol. Cancer Ther., 2015, Vol. 14, no. 6, pp. 1385-1394.</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru">Voskoboinik I., Whisstock J.C., Trapani J.A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol., 2015, Vol. 15, no. 6, pp. 388-400.</mixed-citation><mixed-citation xml:lang="en">Voskoboinik I., Whisstock J.C., Trapani J.A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol., 2015, Vol. 15, no. 6, pp. 388-400.</mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Wang R., Jaw J.J., Stutzman N.C., Zou Z., Sun P.D. Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1. J. Leukoc. Biol., 2012, Vol. 91, no. 2, pp. 299-309.</mixed-citation><mixed-citation xml:lang="en">Wang R., Jaw J.J., Stutzman N.C., Zou Z., Sun P.D. Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1. J. Leukoc. Biol., 2012, Vol. 91, no. 2, pp. 299-309.</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru">Wei J., Satomi M., Negishi Y., Matsumura Y., Miura A., Nishi Y., Asakura H., Takeshita T. Effect of sera on the adhesion of natural killer cells to the endothelium in severe pre-eclampsia. J. Obstet. Gynaecol. Res., 2006, Vol. 32, no. 5, pp. 443-448.</mixed-citation><mixed-citation xml:lang="en">Wei J., Satomi M., Negishi Y., Matsumura Y., Miura A., Nishi Y., Asakura H., Takeshita T. Effect of sera on the adhesion of natural killer cells to the endothelium in severe pre-eclampsia. J. Obstet. Gynaecol. Res., 2006, Vol. 32, no. 5, pp. 443-448.</mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Woodfin A., Voisin M.B., Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol., 2007, Vol. 27, no. 12, pp. 2514-2523.</mixed-citation><mixed-citation xml:lang="en">Woodfin A., Voisin M.B., Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol., 2007, Vol. 27, no. 12, pp. 2514-2523.</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J., Gao F.X., Wang C., Qin M., Han F., Xu T., Hu Z., Long Y., He X.M., Deng X., Ren D.L., Dai T.Y. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res., 2019, Vol. 38, no. 1, 321. doi: 10.1186/s13046-019-1310-0.</mixed-citation><mixed-citation xml:lang="en">Wu J., Gao F.X., Wang C., Qin M., Han F., Xu T., Hu Z., Long Y., He X.M., Deng X., Ren D.L., Dai T.Y. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res., 2019, Vol. 38, no. 1, 321. doi: 10.1186/s13046-019-1310-0.</mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaguchi T., Kitaya K., Daikoku N., Yasuo T., Fushiki S., Honjo H. Potential selectin L ligands involved in selective recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. Biol. Reprod., 2006, Vol. 74, no. 1, pp. 35-40.</mixed-citation><mixed-citation xml:lang="en">Yamaguchi T., Kitaya K., Daikoku N., Yasuo T., Fushiki S., Honjo H. Potential selectin L ligands involved in selective recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. Biol. Reprod., 2006, Vol. 74, no. 1, pp. 35-40.</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru">Yokoyama W.M., Riley J.K. NK cells and their receptors. Reprod. Biomed. Online, 2008, Vol. 16, no. 2, pp. 173-191.</mixed-citation><mixed-citation xml:lang="en">Yokoyama W.M., Riley J.K. NK cells and their receptors. Reprod. Biomed. Online, 2008, Vol. 16, no. 2, pp. 173-191.</mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Yu J., Freud A.G., Caligiuri M.A. Location and cellular stages of natural killer cell development. Trends Immunol., 2013, Vol. 34, no. 12, pp. 573-582.</mixed-citation><mixed-citation xml:lang="en">Yu J., Freud A.G., Caligiuri M.A. Location and cellular stages of natural killer cell development. Trends Immunol., 2013, Vol. 34, no. 12, pp. 573-582.</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru">Zaiatz-Bittencourt V., Finlay D.K., Gardiner C.M. Canonical TGF-beta signaling pathway represses human NK cell metabolism. J. Immunol., 2018, Vol. 200, no. 12, pp. 3934-3941.</mixed-citation><mixed-citation xml:lang="en">Zaiatz-Bittencourt V., Finlay D.K., Gardiner C.M. Canonical TGF-beta signaling pathway represses human NK cell metabolism. J. Immunol., 2018, Vol. 200, no. 12, pp. 3934-3941.</mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Liu J., Chen H., Wu W., Li X., Wu Y., Wang Z., Zhang K., Li Y., Weng Y., Liao H., Gu L. Specific immunotherapy generates CD8(+) CD196(+) T cells to suppress lung cancer growth in mice. Immunol. Res., 2016, Vol. 64, no. 4, pp. 1033-1040.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Liu J., Chen H., Wu W., Li X., Wu Y., Wang Z., Zhang K., Li Y., Weng Y., Liao H., Gu L. Specific immunotherapy generates CD8(+) CD196(+) T cells to suppress lung cancer growth in mice. Immunol. Res., 2016, Vol. 64, no. 4, pp. 1033-1040.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
